SUMMARY The capacity of circulating neutrophils for activation by complement was studied in outpatients with classical or definite rheumatoid arthritis during treatment with dextropropoxyphene only. Analysis of dose-response in the Boyden chamber assay of chemotaxis showed that sensitivity to the potent, complement derived anaphylatoxin, C5a, was markedly decreased, especially in those patients with few joints involved. In contrast, peak response to C5a was within the normal range. Increased complement 3c split products in plasma of the patients suggested involvement of complement cascade reactions. Subnormal sensitivity of neutrophils to phlogistic mediators released by complement may tend to limit their recruitment and potentially tissue destroying secretion locally in rheumatoid arthritis.
quantified as a parameter of complement catabolism. C3c is released by activation of both the classical and alternative pathways of complement.' 3 
Materials and methods

PATIENT POPULATION
Fifteen consecutive outpatients with classical or definite rheumatoid arthritis according to the criteria of the American Rheumatism Association were studied_. Exclusion cnrteria were: (1) treatment with gold compounds, penicillamine, or steroids within six preceding weeks; and (2) complicating infections or conditions, such as atopy, affecting the immune system. Aspirin and non-steroidal antiinflammatory drugs were withdrawn for a median of 10 days, range 7-18 days, and during this washout period pain was controlled with dextropropoxyphene only. All patients were interviewed and examined by the same physician before drawing blood samples for investigation on the same day. The (Fig. 2) . In contrast, peak response of neutrophils to C5a was normal in the patients (p>010, (Fig. 3) . No significant correlation could be established between other clinical parameters such as duration of the disease or duration of morning stiffness and any neutrophil function test (p> 0-10). Levels of the c split product of C3 (C3c) in the circulation were slightly but significantly raised in rheumatoid arthritis patients (p<0025) (Fig. 4) . This indicator of C3 catabolism did not correlate with clinical parameters recorded.
Cell suspensions ready for chemotaxis experi- ments contained 'a96% neutrophils both in patients and controls, and recovery of these responding cells was 45%.
Discussion
The present study shows a significant abnormality of circulating neutrophils in well established rheuma- 
